Hot blooded: Keros Therapeutics prices upsized IPO at $16, the high end of the range – NasdaqBy / April 7, 2020 Hot blooded: Keros Therapeutics prices upsized IPO at $16, the high end of the range Nasdaq Share this:TweetReddit